loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Q-LINE BIOTECH IPO

CLOSED

IPO Details

21th May 2026
25th May 2026
400
₹ 260,800
₹ 326-343
₹ 214 Crore

Issue timeline

  • 21-25 May 2026
  • 26-May-2026
  • 27-May-2026
  • 27-May-2026
  • 29-May-2026

Subscription Status

Shareholder -
Qualified Institutional Buyers -
Non-Institutional Investor -
Retail Individual Investor -
Employee -
Total -

About Company

Q-Line Biotech was incorporated on November 10, 2010. The company develops, manufactures, and markets diagnostic reagents, kits, consumables, and point-of-care devices, while also supplying diagnostic and pathology equipment for healthcare providers. Its operations span clinical chemistry, haematology, immunodiagnostics, molecular diagnostics, and rapid testing solutions
-
Name Designation
Saurabh Garg Chairman & Managing Director
Kuldeep Chowdhry Whole Time Director
Ajay Kumar Mahanty Whole Time Director
Yethadka Subraya Prabhakara Whole Time Director
Abhay Agrawal Non-Executive Director
Amita Garg Non-Executive Director
Ayush Garg Non-Executive Director
Abhishek Mishra Independent Director
Pravir Kumar Independent Director
Rohit Nandan Independent Director
Jai Prakash Singh Independent Director

Objectives

To meet working capital requirements
Repayment of certain borrowing availed by the company
General corporate purpose

Strengths & Risks

Strengths (2)

The company has established manufacturing capabilities supported by research and development, reverse engineering, and quality control. Its dedicated R&D team focuses on product innovation, process improvement, and efficient manufacturing

Risks (3)

The company relies on agreements with European companies for manufacturing support and raw material supply. Failure to renew these agreements on favorable terms could disrupt operations and impact financial performance

Financials

Frequently Asked Questions

Who are the promoters of Q-Line Biotech Ltd.?

The promoters of the company are Saurabh Garg, Amita Garg, Ajay Kumar Mahanty, Abhay Agrawal and Ayush Garg.

The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.

The price band of the IPO is Rs 326.0 - 343.0.

The IPO application opens on May 21, 2026 and closes on May 25, 2026.

The minimum lot size for the IPO is 800. The maximum lot size for the IPO is 800.

View More

*The financials mentioned above are sourced from DRHP/ RHP documents.